Pure Biologics Spólka Akcyjna
PUR.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | PLN 35,634 | PLN 20,928 | PLN 57,517 | PLN 94,645 |
| - Cash | PLN 112 | PLN 295 | PLN 227 | PLN 313 |
| + Debt | PLN 14,974 | PLN 14,782 | PLN 14,422 | PLN 14,059 |
| Enterprise Value | PLN 50,496 | PLN 35,415 | PLN 71,712 | PLN 108,391 |
| Revenue | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| % Growth | – | – | – | – |
| Gross Profit | -PLN 5 | -PLN 8 | -PLN 6 | -PLN 283 |
| % Margin | – | – | – | – |
| EBITDA | -PLN 850 | -PLN 2,234 | -PLN 742 | -PLN 6,806 |
| % Margin | – | – | – | – |
| Net Income | -PLN 1,215 | -PLN 4,719 | -PLN 1,338 | -PLN 10,656 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.21 | -0.74 | -0.34 | -1.94 |
| % Growth | 71.6% | -117.6% | 82.5% | – |
| Operating Cash Flow | -PLN 216 | -PLN 184 | -PLN 785 | -PLN 3,932 |
| Capital Expenditures | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Free Cash Flow | -PLN 216 | -PLN 184 | -PLN 785 | -PLN 3,932 |